Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
Status: | Completed |
---|---|
Conditions: | Alzheimer Disease |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 50 - Any |
Updated: | 1/27/2018 |
Start Date: | July 2016 |
End Date: | January 5, 2018 |
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial: Further Study, Health Outcome
This study is a retrospective review of the data collected in a previously completed
randomized, controlled trial (RCT) entitled "Memantine and Comprehensive, Individualized,
Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial"
(NCT00120874). As part of the previously completed RCT, participants with Alzheimer's Disease
(AD) were randomly placed into one of two groups: memantine, or memantine plus an
individualized management program consisting of home visits, educational sessions for
caregivers, and a caregiver support group. Participants received the study intervention for
28 weeks; study follow-up lasted for 52 weeks.
The collected data from the existing study books from the 28 week treatment portion of the
RCT will be carefully examined with respect to each of the research questions for the present
retrospective study.
randomized, controlled trial (RCT) entitled "Memantine and Comprehensive, Individualized,
Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial"
(NCT00120874). As part of the previously completed RCT, participants with Alzheimer's Disease
(AD) were randomly placed into one of two groups: memantine, or memantine plus an
individualized management program consisting of home visits, educational sessions for
caregivers, and a caregiver support group. Participants received the study intervention for
28 weeks; study follow-up lasted for 52 weeks.
The collected data from the existing study books from the 28 week treatment portion of the
RCT will be carefully examined with respect to each of the research questions for the present
retrospective study.
Inclusion Criteria:
- Previously participated in the "Memantine and Comprehensive, Individualized, Patient
Centered Management of Alzheimer's Disease: A Randomized Controlled Trial" study.
We found this trial at
1
site
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials